PepGen Inc.
General ticker "PEPG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $79.3M (TTM average)
PepGen Inc. follows the US Stock Market performance with the rate: 31.4%.
Estimated limits based on current volatility of 5.6%: low 5.08$, high 5.68$
Factors to consider:
- Total employees count: 81 as of 2024
- Top business risk factors: Limited operating history, Regulatory and compliance, Strategic risks and growth management, Geopolitical risks, Acquisition/divestiture risks
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.01$, 6.64$]
- 2025-12-31 to 2026-12-31 estimated range: [1.73$, 5.42$]
Financial Metrics affecting the PEPG estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -66.08 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 78.62 > 63.39
Short-term PEPG quotes
Long-term PEPG plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $68.30MM | $84.77MM | $97.74MM |
| Operating Income | $-68.30MM | $-84.77MM | $-97.74MM |
| Non-Operating Income | $2.90MM | $6.21MM | $7.14MM |
| R&D Expense | $54.08MM | $68.13MM | $76.48MM |
| Income(Loss) | $-65.40MM | $-78.55MM | $-90.60MM |
| Taxes | $3.71MM | $0.07MM | $-0.62MM |
| Profit(Loss)* | $-69.10MM | $-78.63MM | $-89.98MM |
| Stockholders Equity | $179.63MM | $108.42MM | $118.62MM |
| Assets | $217.44MM | $143.05MM | $150.88MM |
| Operating Cash Flow | $-59.27MM | $-69.00MM | $-82.37MM |
| Capital expenditure | $3.75MM | $2.60MM | $0.50MM |
| Investing Cash Flow | $-3.75MM | $-32.00MM | $-37.67MM |
| Financing Cash Flow | $112.19MM | $-0.19MM | $88.75MM |
| Earnings Per Share** | $-4.42 | $-3.30 | $-2.85 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.